104 related articles for article (PubMed ID: 26604170)
1. ANP-ing Up Diabetes: Impaired Natriuretic Peptide Action in Muscle Forms a Mechanistic Link Between Obesity and Diabetes.
Cleasby ME
Diabetes; 2015 Dec; 64(12):3978-80. PubMed ID: 26604170
[No Abstract] [Full Text] [Related]
2. Defective Natriuretic Peptide Receptor Signaling in Skeletal Muscle Links Obesity to Type 2 Diabetes.
Coué M; Badin PM; Vila IK; Laurens C; Louche K; Marquès MA; Bourlier V; Mouisel E; Tavernier G; Rustan AC; Galgani JE; Joanisse DR; Smith SR; Langin D; Moro C
Diabetes; 2015 Dec; 64(12):4033-45. PubMed ID: 26253614
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes.
Kovacova Z; Tharp WG; Liu D; Wei W; Xie H; Collins S; Pratley RE
Obesity (Silver Spring); 2016 Apr; 24(4):820-8. PubMed ID: 26887289
[TBL] [Abstract][Full Text] [Related]
4. Dietary fats and insulin action.
Storlien LH; Baur LA; Kriketos AD; Pan DA; Cooney GJ; Jenkins AB; Calvert GD; Campbell LV
Diabetologia; 1996 Jun; 39(6):621-31. PubMed ID: 8781757
[No Abstract] [Full Text] [Related]
5. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.
Verboven K; Hansen D; Jocken JWE; Blaak EE
Obes Rev; 2017 Nov; 18(11):1243-1259. PubMed ID: 28901677
[TBL] [Abstract][Full Text] [Related]
7. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany.
Wabitsch M; Hauner H; Hertrampf M; Muche R; Hay B; Mayer H; Kratzer W; Debatin KM; Heinze E
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):307-13. PubMed ID: 14724655
[TBL] [Abstract][Full Text] [Related]
8. Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ.
Shuldiner AR; Yang R; Gong DW
N Engl J Med; 2001 Nov; 345(18):1345-6. PubMed ID: 11794158
[No Abstract] [Full Text] [Related]
9. Diabetes-induced perturbations are subject to intergenerational transmission through maternal line.
Hanafi MY; Abdelkhalek TM; Saad MI; Saleh MM; Haiba MM; Kamel MA
J Physiol Biochem; 2016 Jun; 72(2):315-26. PubMed ID: 27038466
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction.
Sato S; Ogura Y; Tajrishi MM; Kumar A
FASEB J; 2015 Mar; 29(3):988-1002. PubMed ID: 25466899
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis of insulin resistance in IGT].
Asakawa H; Tokunaga K
Nihon Rinsho; 1997 Nov; 55 Suppl():822-6. PubMed ID: 9434571
[No Abstract] [Full Text] [Related]
13. Effects of chronic elevation of atrial natriuretic peptide and free fatty acid levels in the induction of type 2 diabetes mellitus and insulin resistance in patients with mitral valve disease.
Monti LD; Lucotti PC; Setola E; Rossodivita A; Pala MG; Galluccio E; LaCanna G; Castiglioni A; Cannoletta M; Meloni C; Zavaroni I; Bosi E; Alfieri O; Piatti PM
Nutr Metab Cardiovasc Dis; 2012 Jan; 22(1):58-65. PubMed ID: 20709514
[TBL] [Abstract][Full Text] [Related]
14. Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?
Pivovarova O; Gögebakan Ö; Klöting N; Sparwasser A; Weickert MO; Haddad I; Nikiforova VJ; Bergmann A; Kruse M; Seltmann AC; Blüher M; Pfeiffer AF; Rudovich N
J Clin Endocrinol Metab; 2012 May; 97(5):E731-9. PubMed ID: 22419733
[TBL] [Abstract][Full Text] [Related]
15. [Glucose intolerance with antipsychotic drugs].
Naitoh H; Manabe Y; Iwata N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():329-32. PubMed ID: 15779397
[No Abstract] [Full Text] [Related]
16. [Disorder of glucose metabolism in skeletal muscle].
Horike N; Asano T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():136-40. PubMed ID: 15779357
[No Abstract] [Full Text] [Related]
17. Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.
Moro C
Expert Opin Ther Targets; 2016 Dec; 20(12):1445-1452. PubMed ID: 27786597
[TBL] [Abstract][Full Text] [Related]
18. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue.
Lauro D; Kido Y; Castle AL; Zarnowski MJ; Hayashi H; Ebina Y; Accili D
Nat Genet; 1998 Nov; 20(3):294-8. PubMed ID: 9806552
[TBL] [Abstract][Full Text] [Related]
19. Childhood obesity and type 2 diabetes mellitus.
Hannon TS; Rao G; Arslanian SA
Pediatrics; 2005 Aug; 116(2):473-80. PubMed ID: 16061606
[TBL] [Abstract][Full Text] [Related]
20. Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus.
Sechi LA; Valentin JP; Griffin CA; Lee E; Bartoli E; Humphreys MH; Schambelan M
J Clin Invest; 1995 Jun; 95(6):2451-7. PubMed ID: 7769090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
